APA (7th ed.) Citation

L, F., J, F., E, P., E, A., Y, D., & V, C. (2023). Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols, 12, e43091. https://doi.org/10.2196/43091

Chicago Style (17th ed.) Citation

L, Fraticelli, Freyssenge J, Promé-Combel E, Agnellet E, Dargaud Y, and Chamouard V. "Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model." JMIR Research Protocols 12 (2023): e43091. https://doi.org/10.2196/43091.

MLA (9th ed.) Citation

L, Fraticelli, et al. "Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model." JMIR Research Protocols, vol. 12, 2023, p. e43091, https://doi.org/10.2196/43091.